No pharmacokinetic interaction between raltegravir and amlodipine: importance for co-prescribing in ageing HIV-infected individuals

AIDS. 2014 Aug 24;28(13):1993-5. doi: 10.1097/QAD.0000000000000356.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amlodipine / pharmacokinetics*
  • Amlodipine / therapeutic use
  • Anti-HIV Agents / pharmacokinetics*
  • Anti-HIV Agents / therapeutic use
  • Antihypertensive Agents / pharmacokinetics*
  • Antihypertensive Agents / therapeutic use
  • Chromatography, Liquid
  • Cross-Over Studies
  • Drug Interactions*
  • Female
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • Humans
  • Hypertension / complications
  • Hypertension / drug therapy*
  • Male
  • Middle Aged
  • Plasma / chemistry
  • Pyrrolidinones / pharmacokinetics*
  • Pyrrolidinones / therapeutic use
  • Raltegravir Potassium
  • Tandem Mass Spectrometry
  • Time Factors
  • Young Adult

Substances

  • Anti-HIV Agents
  • Antihypertensive Agents
  • Pyrrolidinones
  • Amlodipine
  • Raltegravir Potassium